Analysis of Investigational Drugs in Biological Fluids - Method Development and Analysis of Pre-Clinical Samples
Abstract
Work on development and/or validation of analytical methodologies during the current contract focused on assays for WR 6026 (and its metabolites, WR 211789 and WR 254421), mefloquine (and its metabolite, WR 160972), p-aminoheptanophenone (and related compounds), WR 242511, halofantrine (and its metabolite, WR 178,460, and their stereoisomers), chloroquine (and its metabolites, monodesethylchoroquine and didesethyichloroquine), WR 243,251, WR 238,605, gentamicin, paromomycin and artelinic acid (and metabolites and artesunate). Work on routine analyses of biological specimens during this period was performed for studies that required determination of concentrations of artelinic acid, choroquine (and its metabolites, monodesethyichloroquine and didesethylchloroquine), and stereoisomers of halofantrine (and its metabolite, WR 178,460).
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2001
- Accession Number
- ADA399915
Entities
People
- Emil T. Lin
Organizations
- University of California, San Francisco